CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >
Difference analysis of the gut microbiome in patients with echinococcosis
Received date: 2022-04-14
Revised date: 2022-10-09
Online published: 2023-02-22
Supported by
National Natural Science Foundation of China(NSFC 8196057);Qinghai Science and Technology Department Project(2019-SF-131)
Fecal samples of 13 patients (7 patients with alveolar echinococcosis, 6 patients with cystic echinococcosis as infected group) and 13 healthy family members caring for patients (as control group) were collected in the Department of Hepatobiliary Surgery of Qinghai University Affiliated Hospital from October to December in 2020. The fecal DNA was extracted and the concentration was determined, and the cDNA library was synthesized by reverse transcription, and then sequenced using the metagenomic next generation sequencing. The metagenome second-generation sequencing was used to observe the changes of intestinal flora. Linear discriminant analysis was used to analyse the differences in intestinal flora between echinococcosis patients and healthy controls. The results revealed that the flora with higher relative abundance in the alveolar echinococcosis group were Alistipes onderdonkii, Bacteroides dorei, A. finegoldii, and the flora with higher relative abundance in the cystic echinococcosis group were A. shahii, Methanobrevibacter smithii, Streptococcus vestibularis. In the healthy individuals group, there were high relative abundance of B. caccae, Bifidobacterium adolescentis, Phascolarctobacterium succinatutens. Among them, A. onderdonkii, A. shahii and B. caccae are more meaningful flora. The differential flora in this study may be the intestinal microbial marker of echinococcosis, which deserves further to study.
CAO Deping , WU Defang , PANG Mingquan , PENG Xiaohong , LI Dayu , FAN Haining . Difference analysis of the gut microbiome in patients with echinococcosis[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023 , 41(1) : 103 -107 . DOI: 10.12140/j.issn.1000-7423.2023.01.016
| [1] | Wu ZD, Zhu XP. Human parasitology[M]. 3rd ed. Beijing: People’s Medical Publishing House, 2015: 214-216. (in Chinese) |
| (吴忠道, 诸欣平. 人体寄生虫学[M]. 3版. 北京: 人民卫生出版社, 2015: 214-216.) | |
| [2] | Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075-e00018. |
| [3] | Sender R. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans[J]. Cell, 2016, 164(3): 337-340. |
| [4] | Gui QF, Jin HL, Zhu F, et al. Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case-control study[J]. Infect Dis Poverty, 2021, 10: 43. |
| [5] | Schroeder BO, B?ckhed F. Signals from the gut microbiota to distant organs in physiology and disease[J]. Nat Med, 2016, 22(10): 1079-1089. |
| [6] | Schluter J, Peled JU, Taylor BP, et al. The gut microbiota is associated with immune cell dynamics in humans[J]. Nature, 2020, 588(7837): 303-307. |
| [7] | Qin N, Yang FL, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis[J]. Nature, 2014, 513(7516): 59-64. |
| [8] | Zhao Y, Yang S, Li B, et al. Alterations of the mice gut microbiome via Schistosoma japonicum Ova-induced granuloma[J]. Front Microbiol, 2019, 10: 352. |
| [9] | Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. (in Chinese) |
| (中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721.) | |
| [10] | Menzel P, Ng KL, Krogh A. Fast and sensitive taxonomic classification for metagenomics with Kaiju[J]. Nat Commun, 2016, 7: 11257. |
| [11] | Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora[J]. Science, 2005, 308(5728): 1635-1638. |
| [12] | Kazemian N, Mahmoudi M, Halperin F, et al. Gut microbiota and cardiovascular disease: Opportunities and challenges[J]. Microbiome, 2020, 8(1): 36. |
| [13] | Wu YH. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease[J]. Life Sci, 2021, 265: 118738. |
| [14] | Bajaj JS. Altered profile of human gut microbiome is associated with cirrhosis and its complications[J]. J Hepatol, 2014, 60(5): 940-947. |
| [15] | Minemura M. Gut microbiota and liver diseases[J]. World J Gastroenterol, 2015, 21(6): 1691. |
| [16] | Jakobsson HE, Rodríguez-Pi?eiro AM, Schütte A, et al. The composition of the gut microbiota shapes the colon mucus barrier[J]. EMBO Rep, 2015, 16(2): 164-177. |
| [17] | Tyrrell KL. Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods[J]. Anaerobe, 2011, 17(3): 130-134. |
| [18] | Parker BJ, Wearsch PA, Veloo ACM, et al. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health[J]. Front Immunol, 2020, 11: 906. |
| [19] | Nakajima A, Sasaki T, Itoh K, et al. A soluble fiber diet increases Bacteroides fragilis group abundance and immunoglobulin A production in the gut[J]. Appl Environ Microbiol, 2020, 86(13): 405-420. |
| [20] | Wei B, Dalwadi H, Gordon LK, et al. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody[J]. Infect Immun, 2001, 69 (10): 6044-6054. |
/
| 〈 |
|
〉 |